These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 38042367)

  • 1. A case of fatal monkeypox infection: necropsy and molecular findings, with some considerations related to clinical management.
    Paniagua-García M; Casimiro-Soriguer CS; Chinchón D; Navarro-Amuedo MD; Luque-Márquez R; de Álava E; Lepe JA; Cisneros JM
    Clin Microbiol Infect; 2024 Mar; 30(3):395.e1-395.e4. PubMed ID: 38042367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mpox in people with advanced HIV infection: a global case series.
    Mitjà O; Alemany A; Marks M; Lezama Mora JI; Rodríguez-Aldama JC; Torres Silva MS; Corral Herrera EA; Crabtree-Ramirez B; Blanco JL; Girometti N; Mazzotta V; Hazra A; Silva M; Montenegro-Idrogo JJ; Gebo K; Ghosn J; Peña Vázquez MF; Matos Prado E; Unigwe U; Villar-García J; Wald-Dickler N; Zucker J; Paredes R; Calmy A; Waters L; Galvan-Casas C; Walmsley S; Orkin CM;
    Lancet; 2023 Mar; 401(10380):939-949. PubMed ID: 36828001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Mpox with Suspected Tecovirimat Resistance in Immunocompromised Patient, United States, 2022.
    Contag CA; Mische L; Fong I; Karan A; Vaidya A; McCormick DW; Bower W; Hacker JK; Johnson K; SanJuan P; Crebbin L; Temmins C; Sahni H; Bogler Y; Cooper JD; Narasimhan S
    Emerg Infect Dis; 2023 Dec; 29(12):2520-2523. PubMed ID: 37856215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mpox and HIV-Collision of Two Diseases.
    Zucker J; Hazra A; Titanji BK
    Curr HIV/AIDS Rep; 2023 Dec; 20(6):440-450. PubMed ID: 37994953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mpox as AIDS-defining event with a severe and protracted course: clinical, immunological, and virological implications.
    Pinnetti C; Cimini E; Mazzotta V; Matusali G; Vergori A; Mondi A; Rueca M; Batzella S; Tartaglia E; Bettini A; Notari S; Rubino M; Tempestilli M; Pareo C; Falasca L; Del Nonno F; Scarabello A; Camici M; Gagliardini R; Girardi E; Vaia F; Maggi F; Agrati C; Antinori A
    Lancet Infect Dis; 2024 Feb; 24(2):e127-e135. PubMed ID: 37778364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mpox and HIV: a Narrative Review.
    Saldana CS; Kelley CF; Aldred BM; Cantos VD
    Curr HIV/AIDS Rep; 2023 Aug; 20(4):261-269. PubMed ID: 37178205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tecovirimat for the treatment of severe Mpox in Germany.
    Hermanussen L; Brehm TT; Wolf T; Boesecke C; Schlabe S; Borgans F; Monin MB; Jensen BO; Windhaber S; Scholten S; Jordan S; Lütgehetmann M; Wiesch JSZ; Addo MM; Mikolajewska A; Niebank M; Schmiedel S
    Infection; 2023 Oct; 51(5):1563-1568. PubMed ID: 37273167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tecovirimat Treatment of People With HIV During the 2022 Mpox Outbreak : A Retrospective Cohort Study.
    McLean J; Stoeckle K; Huang S; Berardi J; Gray B; Glesby MJ; Zucker J
    Ann Intern Med; 2023 May; 176(5):642-648. PubMed ID: 37126820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical considerations on monkeypox antiviral medications: An overview.
    Pourkarim F; Entezari-Maleki T
    Pharmacol Res Perspect; 2024 Feb; 12(1):e01164. PubMed ID: 38149674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe Mpox Infections in People With Uncontrolled Human Immunodeficiency Virus.
    Govind A; Lazarte SM; Kitchell E; Chow JY; Estelle CD; Fixsen E; Helm C; Jain MK; Mehta R; Perl TM; Sutaria JM; Thomas C; Dominguez AR; Utay NS
    Clin Infect Dis; 2023 May; 76(10):1843-1846. PubMed ID: 36718662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monkeypox (mpox) in immunosuppressed patients.
    Ahmed SK; Mohamed MG; Dabou EA; Abuijlan I; Chandran D; El-Shall NA; Chopra H; Dhama K
    F1000Res; 2023; 12():127. PubMed ID: 37089133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mpox Genital Lesions: A Large Single-center Experience With Intermediate Follow-up.
    Lee J; McLean J; Zucker J; Brandes S; Joice G
    J Urol; 2023 Sep; 210(3):510-516. PubMed ID: 37294043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 40-Year-Old Man with Anemia, Proctitis, Rectal Bleeding, and a Perianal Rash Due to Mpox (Monkeypox) Infection.
    Moore C; Marcucci V; Torres P; Liu E; Parker GS
    Am J Case Rep; 2023 Sep; 24():e940177. PubMed ID: 37660250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interim Clinical Treatment Considerations for Severe Manifestations of Mpox - United States, February 2023.
    Rao AK; Schrodt CA; Minhaj FS; Waltenburg MA; Cash-Goldwasser S; Yu Y; Petersen BW; Hutson C; Damon IK
    MMWR Morb Mortal Wkly Rep; 2023 Mar; 72(9):232-243. PubMed ID: 36862595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trifluridine for treatment of mpox infection in drug combinations in ophthalmic cell models.
    Cinatl J; Bechtel M; Reus P; Ott M; Rothweiler F; Michaelis M; Ciesek S; Bojkova D
    J Med Virol; 2024 Jan; 96(1):e29354. PubMed ID: 38180134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mpox in people with past infection or a complete vaccination course: a global case series.
    Hazra A; Zucker J; Bell E; Flores J; Gordon L; Mitjà O; Suñer C; Lemaignen A; Jamard S; Nozza S; Nori AV; Pérez-Barragán E; Rodríguez-Aldama JC; Blanco JL; Delaugerre C; Turner D; Fuertes I; Leiro V; Walmsley SL; Orkin CM;
    Lancet Infect Dis; 2024 Jan; 24(1):57-64. PubMed ID: 37678309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and management of individuals admitted to hospital with monkeypox and associated complications across the UK: a retrospective cohort study.
    Fink DL; Callaby H; Luintel A; Beynon W; Bond H; Lim EY; Gkrania-Klotsas E; Heskin J; Bracchi M; Rathish B; Milligan I; O'Hara G; Rimmer S; Peters JR; Payne L; Mody N; Hodgson B; Lewthwaite P; Lester R; Woolley SD; Sturdy A; Whittington A; Johnson L; Jacobs N; Quartey J; Ai Payne B; Crowe S; Elliott IA; Harrison T; Cole J; Beard K; Cusack TP; Jones I; Banerjee R; Rampling T; ; Dunning J
    Lancet Infect Dis; 2023 May; 23(5):589-597. PubMed ID: 36566771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal management of severe mpox in patients with uncontrolled human immunodeficiency virus.
    Shishido AA; Street S
    J Med Virol; 2023 Dec; 95(12):e29277. PubMed ID: 38078663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and predictors of human mpox outcome during the 2022 outbreak in Nigeria: a cohort study.
    Ogoina D; Dalhat MM; Denue BA; Okowa M; Chika-Igwenyi NM; Yusuff HA; Christian UC; Adekanmbi O; Ojimba AO; Aremu JT; Habila KL; Oiwoh SO; Tobin EA; Johnson SM; Olaitan A; Onyeaghala C; Gomerep SS; Alasia D; Onukak AE; Mmerem J; Unigwe U; Falodun O; Kwaghe V; Awang SK; Sunday M; Maduka CJ; Na'uzo AM; Owhin SO; Mohammed AA; Adeiza MA;
    Lancet Infect Dis; 2023 Dec; 23(12):1418-1428. PubMed ID: 37625431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prior viral infection determines the mode and severity of monkeypox virus.
    Hussain H; Paidas MJ; Fadel A; Ramamoorthy R; Garcia E; Saadoon ZF; Casmartino E; Mendez L; Williams EA; Ruiz-Cordero R; Jayakumar AR
    Int J Infect Dis; 2023 Jun; 131():95-99. PubMed ID: 37001797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.